GERON CORP (GERN)
Pharmaceutical Preparations
Latest Price
$1.29
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
342.27
P/B Ratio
0.00
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 63.77M | $95.0M | -- | -- | 2026-03-31 |
| BlackRock, Inc. | 47.32M | $70.0M | -- | +1.41M | 2026-03-31 |
| Soleus Capital Management, L.P. | 41.51M | $61.0M | -- | +18.22M | 2026-03-31 |
| Deep Track Capital, LP | 31.72M | $47.0M | -- | -791.0K | 2026-03-31 |
| STATE STREET CORP | 30.50M | $45.0M | -- | +3.63M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 26.67M | $39.0M | -- | -- | 2026-03-31 |
| CITADEL ADVISORS LLC | 22.11M | $32.0M | -- | +11.35M | 2026-03-31 |
| Point72 Asset Management, L.P. | 20.46M | $30.0M | -- | +10.85M | 2026-03-31 |
| Clearbridge Investments, LLC | 19.62M | $29.0M | -- | +5.38M | 2026-03-31 |
| Eversept Partners, LP | 18.83M | $28.0M | -- | +1.17M | 2026-03-31 |